HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK Sunscreen Claims On ‘Negligible’ Difference In SPF Strengths Don't Add Up

Executive Summary

Advertising Standards Authority says Green People Co. misled consumers with claims SPF 30 formulas filter out only 1% less UVB rays than SPF 50, trying to draw a negligible difference between the formulas. The claims appeared in a direct mailer and on the brand’s website in July 2019.

You may also be interested in...



P&G Saves Face In UK Review Of Olay SPF Claims

P&G Health & Beauty Care can continue promoting two Olay facial skin care products as protecting against the sun as well as SPF30 sunscreens, with consumers unlikely to view the products as substitutes for "primary" sunscreens, says UK Advertising Standards Authority.

L’Oreal UK Airs '5-Star' Kids Sunscreen Ads With '3-Star' Products On Shelves

ASA says TV and radio ads for Ambre Solair Kids Sensitive Advanced sunscreens aired by Loreal Ltd. business implied that all of the brand's products on shelves met a 5-star rating system administered by Boots drug store chain and widely used in UK.

FDA’s Proposed Sunscreen Rule Could Bring SPFs Back Down To Earth, Deter SPF Fraud Suits

SPF claims would be capped at SPF 60+ under FDA’s proposed rule, and companies would be required to label products using the lowest SPF measured in testing and maintain test records that would be accessible to FDA during inspections. The proposal also includes new broad-spectrum requirements, among a host of other changes.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149735

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel